Document Detail

Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
MedLine Citation:
PMID:  9009443     Owner:  NLM     Status:  MEDLINE    
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired chronic hemolytic anemia characterized by intravascular hemolysis, often associated with neutropenia and thrombocytopenia. Venous thrombosis, including the Budd-Chiari syndrome, is one of the major complications of PNH, but not all PNH patients develop thrombosis. The basis for the high risk of thrombosis in PNH is not known. Recent reports have shown that Factor V Leiden mutation is a common cause of increased tendency to develop thrombosis. Fifty-six PNH patients were tested for Factor V Leiden mutation using Amplification Created Restriction Enzyme Site methods. PNH patients do not show an increased frequency of Factor V Leiden mutations.
K Nafa; M Bessler; P Mason; T Vulliamy; P Hillmen; H Castro-Malaspina; L Luzzatto
Related Documents :
8373903 - Severe autoimmune hemolytic anemia with cold agglutinin and sclerodermic features--favo...
18665833 - Stuttering priapism complicating warfarin therapy in a patient with protein c deficiency.
3154573 - Leiomyosarcoma of the orbit. a case report and review of the literature.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Haematologica     Volume:  81     ISSN:  0390-6078     ISO Abbreviation:  Haematologica     Publication Date:    1996 Nov-Dec
Date Detail:
Created Date:  1997-02-28     Completed Date:  1997-02-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  540-2     Citation Subset:  IM    
Department of Human Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 0021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Factor V / genetics*
Hemoglobinuria, Paroxysmal / blood,  complications,  genetics*
Oligonucleotide Probes
Polymerase Chain Reaction
Thrombophlebitis / blood,  complications,  genetics*
Reg. No./Substance:
0/Oligonucleotide Probes; 0/factor V Leiden; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Successful treatment of hepatic veno-occlusive disease in a peripheral blood progenitor cell transpl...
Next Document:  Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.